Spero Therapeutics Inc. (SPRO)
NASDAQ: SPRO
· Real-Time Price · USD
1.93
-0.05 (-2.53%)
At close: Aug 15, 2025, 3:59 PM
2.00
3.90%
After-hours: Aug 15, 2025, 06:03 PM EDT
Spero Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 11.8M | 5.87M | 9.36M | 13.47M | 6.02M | 4.2M | 71.83M | 25.47M | 788K | 740K | 46.3M | 1.08M | 896K | 247K | 2.74M | 3.06M | 5.15M | 7.3M |
Cost of Revenue | n/a | n/a | n/a | 2K | 2K | -5.06M | 38K | 108K | 9.51M | 8.98M | 361K | 7.36M | 8.17M | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 11.8M | 5.87M | 9.36M | 13.47M | 6.01M | 9.27M | 71.79M | 25.36M | -8.72M | -8.24M | 45.94M | -6.28M | -7.28M | 247K | 2.74M | 3.06M | 5.15M | 7.3M |
Operating Income | -2.44M | -14.73M | -21.73M | -18.59M | -19.06M | -13.98M | 50.53M | -1.93M | -12.89M | -14.23M | 25.92M | -11.83M | -26.08M | -30.21M | -27.5M | -22.52M | -18.54M | -19.4M |
Interest Income | 740K | 864K | 1.03M | 1.18M | 1.2M | 1.33M | 1.04M | 950K | 982K | 963K | 715K | 208K | 111K | 72K | 76K | 90K | 82K | 98K |
Pretax Income | -1.7M | -14.73M | -20.6M | -17.44M | -17.86M | -12.67M | 51.58M | -994K | -11.91M | -13.27M | 26.77M | -11.68M | -28.68M | -32.83M | -29.24M | -22.52M | -18.57M | -19.42M |
Net Income | -1.7M | -14.73M | -20.89M | -17.15M | -17.86M | -12.67M | 51.19M | -3.21M | -11.91M | -12.3M | 26.77M | -11.68M | -28.68M | -35.45M | -29.24M | -22.52M | -18.57M | -19.42M |
Selling & General & Admin | 5.88M | 6.82M | 7.06M | 5.2M | 5.53M | 5.92M | 6.43M | 5.71M | 6.1M | 7.32M | 6.5M | 6.63M | 8.05M | 15.3M | 13.02M | 11.15M | 9.23M | 8.3M |
Research & Development | 10.67M | 13.61M | 28.84M | 26.86M | 23.73M | 17.33M | 16.52M | 16.39M | 9.51M | 8.98M | 15.09M | 7.36M | 8.17M | 16.97M | 17.23M | 14.44M | 14.46M | 18.4M |
Other Expenses | -2.3M | 175K | -19.7M | n/a | n/a | -5.06M | n/a | 5.31M | -6K | -1.33M | -1.09M | -23K | -10K | -1.82M | -78K | -87K | -112K | -118K |
Operating Expenses | 14.25M | 20.61M | 16.19M | 32.06M | 29.26M | 18.19M | 22.95M | 27.41M | 13.68M | 14.97M | 20.5M | 13.07M | 15.13M | 30.45M | 30.25M | 25.59M | 23.69M | 26.7M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.4K | n/a | 117K | 2.49M | 1.94M | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 14.25M | 20.61M | 16.19M | 32.06M | 29.26M | 23.25M | 22.99M | 27.41M | 13.68M | 14.97M | 20.5M | 13.07M | 15.13M | 30.45M | 30.25M | 25.59M | 23.69M | 26.7M |
Income Tax Expense | n/a | n/a | 290K | -290K | n/a | -91.75K | 387K | -2.21M | -6K | -961K | 1.98K | -23K | 107K | 2.62M | n/a | -90K | -82K | -98K |
Shares Outstanding (Basic) | 56.03M | 55.38M | 54.04M | 54.12M | 53.96M | 53.52M | 53M | 52.71M | 52.57M | 52.53M | 48.72M | 35.88M | 32.98M | 32.5M | 32.13M | 32.13M | 29.48M | 29.41M |
Shares Outstanding (Diluted) | 56.03M | 55.38M | 54.04M | 54.12M | 53.96M | 53.52M | 53.11M | 52.71M | 52.57M | 52.53M | 48.72M | 35.88M | 32.98M | 32.61M | 32.13M | 32.13M | 29.68M | 29.41M |
EPS (Basic) | -0.03 | -0.25 | -0.39 | -0.32 | -0.33 | -0.24 | 0.97 | -0.06 | -0.23 | -0.23 | 0.55 | -0.33 | -0.87 | -1.09 | -0.91 | -0.7 | -0.63 | -0.66 |
EPS (Diluted) | -0.03 | -0.25 | -0.39 | -0.32 | -0.33 | -0.24 | 0.96 | -0.06 | -0.23 | -0.23 | 0.55 | -0.33 | -0.87 | -1.09 | -0.91 | -0.7 | -0.63 | -0.66 |
EBITDA | -2.36M | -14.73M | -20.85M | -18.59M | -19.06M | -13.89M | 51.62M | -886K | -12.78M | -14.11M | 27.13M | -11.42M | -26.08M | -30.15M | -27.25M | -22.38M | -18.39M | -19.24M |
EBIT | -2.36M | -14.73M | -20.85M | -18.59M | -19.06M | -13.98M | 51.58M | -994K | -12.89M | -14.23M | 26.77M | -11.68M | -28.57M | -30.34M | -27.35M | -22.52M | -18.57M | -19.42M |
Depreciation & Amortization | n/a | n/a | n/a | 2K | 2K | 91.75K | 38K | 108K | 348K | 349K | 361K | 257K | 12.24M | 248K | 191K | 148K | 148K | 159K |